Law Firm Probes Option Care Health Over Shareholder Rights
Monteverde & Associates has launched an investigation into Option Care Health amid potential shareholder concerns at the NASDAQ-listed infusion services company.
A New York-based class action law firm has announced an investigation into Option Care Health, Inc. (NASDAQ: OPCH), signaling potential legal scrutiny over matters that could affect the company's shareholders, according to a statement released Monday.
Monteverde & Associates PC, led by class action attorney Juan Monteverde, disclosed the probe. The firm has been recognized as a Top 50 firm in the 2025 ISS Securities Class Action Services Report and has previously recovered millions of dollars on behalf of shareholders in similar cases.
Read more Retail Investing Platforms Top 41 Million Accounts in Record Quarter →
The announcement follows a pattern common in mergers-and-acquisitions litigation, where law firms examine whether company boards have fulfilled their fiduciary duties to shareholders — particularly in the context of potential buyouts, mergers, or other significant corporate transactions. No specific allegations against Option Care Health have been detailed in the initial disclosure.
Option Care Health is a prominent provider of home and alternate-site infusion therapy services and trades on the NASDAQ exchange under the ticker OPCH. The company's shareholders may be encouraged by the firm to come forward with relevant information as the investigation proceeds.
Shareholders seeking additional details or wishing to learn more about their legal rights are typically advised to consult with counsel before any relevant deadlines. Continue reading at All Financial Services & Investing.